Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Index funds offer low fees and broad diversification, making them a solid default choice for long-term investors.
26,735 articlesA private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
The Australian government is considering changes to the 50% capital gains discount for assets held over a year, a mov...
Record gold prices and rising demand push Southeast Asia's corporate leaders higher on this year’s SEA 500 list, led ...
As AI stocks surge, Wall Street may signal overvaluation. I break down the arguments, share why I disagree, and give ...
A high-stakes clash between AI safety and national security is unfolding. Anthropic won’t lift safeguards even as the...
Morgan Stanley warns a disruption through the Strait of Hormuz could lift Brent to as high as $150 a barrel by summer...
Investors are buzzing about QuantumScape after news of a major automaker collaboration. This article breaks down what...
A high-profile shift at Base has changed the project’s direction. Jesse Pollak is stepping back from app leadership t...
A shifting geopolitical landscape intersects AI, policy, and crypto. This article breaks down what Anthropic's used I...
A courtroom twist showed how quickly legal drama can upend finances. This deep dive draws practical money lessons fro...
Rumors of Prince Archie and Princess Lilibet returning to the U.K. focus attention on the money side of royal travel....
The memory market is showing persistent strength, and SK Hynix sits at the center of the narrative. This article expl...